Loading…
Porphyrin-Mediated Boron Neutron Capture Therapy: A Preclinical Evaluation of the Response of the Oral Mucosa
Morris, G. M., Coderre, J. A., Micca, P. L., Nawrocky, M. M., Hopewell, J. W. and Miura, M. Porphyrin-Mediated Boron Neutron Capture Therapy: A Preclinical Evaluation of the Response of the Oral Mucosa. Radiat. Res. 163, 72– 78 (2005). Preclinical studies are in progress to determine the potential o...
Saved in:
| Published in: | Radiation research 2005-01, Vol.163 (1), p.72-78 |
|---|---|
| Main Authors: | , , , , , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Citations: | Items that this one cites Items that cite this one |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | cdi_FETCH-LOGICAL-b327t-e8e27835afeb8a94c2d2dbe4e21bd4945c1ed98cdbe587020231f97f7ef80353 |
|---|---|
| cites | cdi_FETCH-LOGICAL-b327t-e8e27835afeb8a94c2d2dbe4e21bd4945c1ed98cdbe587020231f97f7ef80353 |
| container_end_page | 78 |
| container_issue | 1 |
| container_start_page | 72 |
| container_title | Radiation research |
| container_volume | 163 |
| creator | Morris, G. M. Coderre, J. A. Micca, P. L. Nawrocky, M. M. Hopewell, J. W. Miura, M. |
| description | Morris, G. M., Coderre, J. A., Micca, P. L., Nawrocky, M. M., Hopewell, J. W. and Miura, M. Porphyrin-Mediated Boron Neutron Capture Therapy: A Preclinical Evaluation of the Response of the Oral Mucosa. Radiat. Res. 163, 72– 78 (2005). Preclinical studies are in progress to determine the potential of boron neutron capture therapy (BNCT) for the treatment of carcinomas of the head and neck. Recently, it has been demonstrated that various boronated porphyrins can target a variety of tumor types. Of the porphyrins evaluated so far, copper tetracarboranylphenyl porphyrin (CuTCPH) is potentially a strong candidate for clinical use. In the present investigation, the response of the oral mucosa to CuTCPH-mediated boron neutron capture (BNC) irradiation was assessed using the ventral surface of the tongue of adult male Fischer 344 rats, a standard rodent model. CuTCPH was administered by intravenous infusion, at a dose of 200 mg/kg body weight, over a 48-h period. Three days after the end of the administration of CuTCPH, biodistribution studies indicated very low levels of boron ( |
| doi_str_mv | 10.1667/RR3272 |
| format | article |
| fullrecord | <record><control><sourceid>jstor_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1667_RR3272</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>4138631</jstor_id><sourcerecordid>4138631</sourcerecordid><originalsourceid>FETCH-LOGICAL-b327t-e8e27835afeb8a94c2d2dbe4e21bd4945c1ed98cdbe587020231f97f7ef80353</originalsourceid><addsrcrecordid>eNp1kEtLw0AUhQdRbK36C0RmIe6i88hj4q4t9QGtLaX7MJm5oSlpJswkQv-9U1J15epy7vm4l3MQuqXkicZx8rxec5awMzSkKRdBFJLwHA0J4TxIIpEM0JVzO-I1jdNLNKBRTGJO0iHar4xttgdb1sECdClb0HhirKnxJ3TtcU5l03YW8GYLVjaHFzzGKwuqKutSyQrPvmTVybb0pClwuwW8BteY2sGPXlqPLTplnLxGF4WsHNyc5ghtXmeb6XswX759TMfzIPcp2gAEsETwSBaQC5mGimmmcwiB0VyHaRgpCjoVyu98OMII47RIkyKBQhAe8RF67M8qa5yzUGSNLffSHjJKsmNdWV-XB-97sOnyPeg_7NSPB-56YOdaY3_9kHIRc-rth97OS2Nq-O_NN4MKers</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Porphyrin-Mediated Boron Neutron Capture Therapy: A Preclinical Evaluation of the Response of the Oral Mucosa</title><source>JSTOR</source><creator>Morris, G. M. ; Coderre, J. A. ; Micca, P. L. ; Nawrocky, M. M. ; Hopewell, J. W. ; Miura, M.</creator><creatorcontrib>Morris, G. M. ; Coderre, J. A. ; Micca, P. L. ; Nawrocky, M. M. ; Hopewell, J. W. ; Miura, M.</creatorcontrib><description>Morris, G. M., Coderre, J. A., Micca, P. L., Nawrocky, M. M., Hopewell, J. W. and Miura, M. Porphyrin-Mediated Boron Neutron Capture Therapy: A Preclinical Evaluation of the Response of the Oral Mucosa. Radiat. Res. 163, 72– 78 (2005). Preclinical studies are in progress to determine the potential of boron neutron capture therapy (BNCT) for the treatment of carcinomas of the head and neck. Recently, it has been demonstrated that various boronated porphyrins can target a variety of tumor types. Of the porphyrins evaluated so far, copper tetracarboranylphenyl porphyrin (CuTCPH) is potentially a strong candidate for clinical use. In the present investigation, the response of the oral mucosa to CuTCPH-mediated boron neutron capture (BNC) irradiation was assessed using the ventral surface of the tongue of adult male Fischer 344 rats, a standard rodent model. CuTCPH was administered by intravenous infusion, at a dose of 200 mg/kg body weight, over a 48-h period. Three days after the end of the administration of CuTCPH, biodistribution studies indicated very low levels of boron (<2 μg/g) in the blood. Levels of boron in tongue tissue were 39.0 ± 3.8 μg/g at this time. This was the time selected for irradiation with single doses of thermal neutrons from the Brookhaven Medical Research Reactor. The estimated level of boron-10 in the oral mucosa was used in the calculation of the physical radiation doses from the 10B(n,α)7Li reaction. This differs from the approach using the present generation of clinical boron carriers, where boron levels in blood at the time of irradiation are used for this calculation. Dose–response curves for the incidence of mucosal ulceration were fitted using probit analysis, and the doses required to produce a 50% incidence of the effect (ED50 ± SE) were calculated. Analysis of the dose–effect data for CuTCPH-mediated BNC irradiation, compared with those for X rays and thermal neutrons alone, gave a compound biological effectiveness (CBE) factor of ∼0.04. This very low CBE factor would suggest that there was relatively low accumulation of boron in the key target epithelial stem cells of the oral mucosa. As a consequence, with low levels of boron (<2 μg/g) in the blood, the response of the oral mucosa to CuTCPH-mediated BNCT will be governed primarily by the radiation effects of the thermal neutron beam and not from the boron neutron capture reaction [10B(n,α)7Li].</description><identifier>ISSN: 0033-7587</identifier><identifier>EISSN: 1938-5404</identifier><identifier>DOI: 10.1667/RR3272</identifier><identifier>PMID: 15606309</identifier><language>eng</language><publisher>United States: Radiation Research Society</publisher><subject>Animals ; Blood ; Body Burden ; Boron ; Boron neutron capture therapy ; Boron Neutron Capture Therapy - adverse effects ; Boron Neutron Capture Therapy - methods ; Dose-Response Relationship, Radiation ; Drug Evaluation, Preclinical ; Epithelium ; Female ; Irradiation ; Lethal Dose 50 ; Metalloporphyrins - adverse effects ; Metalloporphyrins - therapeutic use ; Mouth ; Mouth Mucosa - pathology ; Mouth Mucosa - radiation effects ; Oral Ulcer - etiology ; Oral Ulcer - pathology ; Radiation dosage ; Radiation Injuries - etiology ; Radiation Injuries - pathology ; Radiotherapy ; Radiotherapy Dosage ; Rats ; Rats, Inbred F344 ; REGULAR ARTICLES ; Relative Biological Effectiveness ; Thermal neutrons ; Tissue Distribution ; Tongue ; Treatment Outcome</subject><ispartof>Radiation research, 2005-01, Vol.163 (1), p.72-78</ispartof><rights>Radiation Research Society</rights><rights>Copyright 2005 Radiation Research Society</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b327t-e8e27835afeb8a94c2d2dbe4e21bd4945c1ed98cdbe587020231f97f7ef80353</citedby><cites>FETCH-LOGICAL-b327t-e8e27835afeb8a94c2d2dbe4e21bd4945c1ed98cdbe587020231f97f7ef80353</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/4138631$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/4138631$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>314,777,781,27905,27906,58219,58452</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15606309$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Morris, G. M.</creatorcontrib><creatorcontrib>Coderre, J. A.</creatorcontrib><creatorcontrib>Micca, P. L.</creatorcontrib><creatorcontrib>Nawrocky, M. M.</creatorcontrib><creatorcontrib>Hopewell, J. W.</creatorcontrib><creatorcontrib>Miura, M.</creatorcontrib><title>Porphyrin-Mediated Boron Neutron Capture Therapy: A Preclinical Evaluation of the Response of the Oral Mucosa</title><title>Radiation research</title><addtitle>Radiat Res</addtitle><description>Morris, G. M., Coderre, J. A., Micca, P. L., Nawrocky, M. M., Hopewell, J. W. and Miura, M. Porphyrin-Mediated Boron Neutron Capture Therapy: A Preclinical Evaluation of the Response of the Oral Mucosa. Radiat. Res. 163, 72– 78 (2005). Preclinical studies are in progress to determine the potential of boron neutron capture therapy (BNCT) for the treatment of carcinomas of the head and neck. Recently, it has been demonstrated that various boronated porphyrins can target a variety of tumor types. Of the porphyrins evaluated so far, copper tetracarboranylphenyl porphyrin (CuTCPH) is potentially a strong candidate for clinical use. In the present investigation, the response of the oral mucosa to CuTCPH-mediated boron neutron capture (BNC) irradiation was assessed using the ventral surface of the tongue of adult male Fischer 344 rats, a standard rodent model. CuTCPH was administered by intravenous infusion, at a dose of 200 mg/kg body weight, over a 48-h period. Three days after the end of the administration of CuTCPH, biodistribution studies indicated very low levels of boron (<2 μg/g) in the blood. Levels of boron in tongue tissue were 39.0 ± 3.8 μg/g at this time. This was the time selected for irradiation with single doses of thermal neutrons from the Brookhaven Medical Research Reactor. The estimated level of boron-10 in the oral mucosa was used in the calculation of the physical radiation doses from the 10B(n,α)7Li reaction. This differs from the approach using the present generation of clinical boron carriers, where boron levels in blood at the time of irradiation are used for this calculation. Dose–response curves for the incidence of mucosal ulceration were fitted using probit analysis, and the doses required to produce a 50% incidence of the effect (ED50 ± SE) were calculated. Analysis of the dose–effect data for CuTCPH-mediated BNC irradiation, compared with those for X rays and thermal neutrons alone, gave a compound biological effectiveness (CBE) factor of ∼0.04. This very low CBE factor would suggest that there was relatively low accumulation of boron in the key target epithelial stem cells of the oral mucosa. As a consequence, with low levels of boron (<2 μg/g) in the blood, the response of the oral mucosa to CuTCPH-mediated BNCT will be governed primarily by the radiation effects of the thermal neutron beam and not from the boron neutron capture reaction [10B(n,α)7Li].</description><subject>Animals</subject><subject>Blood</subject><subject>Body Burden</subject><subject>Boron</subject><subject>Boron neutron capture therapy</subject><subject>Boron Neutron Capture Therapy - adverse effects</subject><subject>Boron Neutron Capture Therapy - methods</subject><subject>Dose-Response Relationship, Radiation</subject><subject>Drug Evaluation, Preclinical</subject><subject>Epithelium</subject><subject>Female</subject><subject>Irradiation</subject><subject>Lethal Dose 50</subject><subject>Metalloporphyrins - adverse effects</subject><subject>Metalloporphyrins - therapeutic use</subject><subject>Mouth</subject><subject>Mouth Mucosa - pathology</subject><subject>Mouth Mucosa - radiation effects</subject><subject>Oral Ulcer - etiology</subject><subject>Oral Ulcer - pathology</subject><subject>Radiation dosage</subject><subject>Radiation Injuries - etiology</subject><subject>Radiation Injuries - pathology</subject><subject>Radiotherapy</subject><subject>Radiotherapy Dosage</subject><subject>Rats</subject><subject>Rats, Inbred F344</subject><subject>REGULAR ARTICLES</subject><subject>Relative Biological Effectiveness</subject><subject>Thermal neutrons</subject><subject>Tissue Distribution</subject><subject>Tongue</subject><subject>Treatment Outcome</subject><issn>0033-7587</issn><issn>1938-5404</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><recordid>eNp1kEtLw0AUhQdRbK36C0RmIe6i88hj4q4t9QGtLaX7MJm5oSlpJswkQv-9U1J15epy7vm4l3MQuqXkicZx8rxec5awMzSkKRdBFJLwHA0J4TxIIpEM0JVzO-I1jdNLNKBRTGJO0iHar4xttgdb1sECdClb0HhirKnxJ3TtcU5l03YW8GYLVjaHFzzGKwuqKutSyQrPvmTVybb0pClwuwW8BteY2sGPXlqPLTplnLxGF4WsHNyc5ghtXmeb6XswX759TMfzIPcp2gAEsETwSBaQC5mGimmmcwiB0VyHaRgpCjoVyu98OMII47RIkyKBQhAe8RF67M8qa5yzUGSNLffSHjJKsmNdWV-XB-97sOnyPeg_7NSPB-56YOdaY3_9kHIRc-rth97OS2Nq-O_NN4MKers</recordid><startdate>200501</startdate><enddate>200501</enddate><creator>Morris, G. M.</creator><creator>Coderre, J. A.</creator><creator>Micca, P. L.</creator><creator>Nawrocky, M. M.</creator><creator>Hopewell, J. W.</creator><creator>Miura, M.</creator><general>Radiation Research Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>200501</creationdate><title>Porphyrin-Mediated Boron Neutron Capture Therapy: A Preclinical Evaluation of the Response of the Oral Mucosa</title><author>Morris, G. M. ; Coderre, J. A. ; Micca, P. L. ; Nawrocky, M. M. ; Hopewell, J. W. ; Miura, M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b327t-e8e27835afeb8a94c2d2dbe4e21bd4945c1ed98cdbe587020231f97f7ef80353</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Animals</topic><topic>Blood</topic><topic>Body Burden</topic><topic>Boron</topic><topic>Boron neutron capture therapy</topic><topic>Boron Neutron Capture Therapy - adverse effects</topic><topic>Boron Neutron Capture Therapy - methods</topic><topic>Dose-Response Relationship, Radiation</topic><topic>Drug Evaluation, Preclinical</topic><topic>Epithelium</topic><topic>Female</topic><topic>Irradiation</topic><topic>Lethal Dose 50</topic><topic>Metalloporphyrins - adverse effects</topic><topic>Metalloporphyrins - therapeutic use</topic><topic>Mouth</topic><topic>Mouth Mucosa - pathology</topic><topic>Mouth Mucosa - radiation effects</topic><topic>Oral Ulcer - etiology</topic><topic>Oral Ulcer - pathology</topic><topic>Radiation dosage</topic><topic>Radiation Injuries - etiology</topic><topic>Radiation Injuries - pathology</topic><topic>Radiotherapy</topic><topic>Radiotherapy Dosage</topic><topic>Rats</topic><topic>Rats, Inbred F344</topic><topic>REGULAR ARTICLES</topic><topic>Relative Biological Effectiveness</topic><topic>Thermal neutrons</topic><topic>Tissue Distribution</topic><topic>Tongue</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Morris, G. M.</creatorcontrib><creatorcontrib>Coderre, J. A.</creatorcontrib><creatorcontrib>Micca, P. L.</creatorcontrib><creatorcontrib>Nawrocky, M. M.</creatorcontrib><creatorcontrib>Hopewell, J. W.</creatorcontrib><creatorcontrib>Miura, M.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Radiation research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Morris, G. M.</au><au>Coderre, J. A.</au><au>Micca, P. L.</au><au>Nawrocky, M. M.</au><au>Hopewell, J. W.</au><au>Miura, M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Porphyrin-Mediated Boron Neutron Capture Therapy: A Preclinical Evaluation of the Response of the Oral Mucosa</atitle><jtitle>Radiation research</jtitle><addtitle>Radiat Res</addtitle><date>2005-01</date><risdate>2005</risdate><volume>163</volume><issue>1</issue><spage>72</spage><epage>78</epage><pages>72-78</pages><issn>0033-7587</issn><eissn>1938-5404</eissn><abstract>Morris, G. M., Coderre, J. A., Micca, P. L., Nawrocky, M. M., Hopewell, J. W. and Miura, M. Porphyrin-Mediated Boron Neutron Capture Therapy: A Preclinical Evaluation of the Response of the Oral Mucosa. Radiat. Res. 163, 72– 78 (2005). Preclinical studies are in progress to determine the potential of boron neutron capture therapy (BNCT) for the treatment of carcinomas of the head and neck. Recently, it has been demonstrated that various boronated porphyrins can target a variety of tumor types. Of the porphyrins evaluated so far, copper tetracarboranylphenyl porphyrin (CuTCPH) is potentially a strong candidate for clinical use. In the present investigation, the response of the oral mucosa to CuTCPH-mediated boron neutron capture (BNC) irradiation was assessed using the ventral surface of the tongue of adult male Fischer 344 rats, a standard rodent model. CuTCPH was administered by intravenous infusion, at a dose of 200 mg/kg body weight, over a 48-h period. Three days after the end of the administration of CuTCPH, biodistribution studies indicated very low levels of boron (<2 μg/g) in the blood. Levels of boron in tongue tissue were 39.0 ± 3.8 μg/g at this time. This was the time selected for irradiation with single doses of thermal neutrons from the Brookhaven Medical Research Reactor. The estimated level of boron-10 in the oral mucosa was used in the calculation of the physical radiation doses from the 10B(n,α)7Li reaction. This differs from the approach using the present generation of clinical boron carriers, where boron levels in blood at the time of irradiation are used for this calculation. Dose–response curves for the incidence of mucosal ulceration were fitted using probit analysis, and the doses required to produce a 50% incidence of the effect (ED50 ± SE) were calculated. Analysis of the dose–effect data for CuTCPH-mediated BNC irradiation, compared with those for X rays and thermal neutrons alone, gave a compound biological effectiveness (CBE) factor of ∼0.04. This very low CBE factor would suggest that there was relatively low accumulation of boron in the key target epithelial stem cells of the oral mucosa. As a consequence, with low levels of boron (<2 μg/g) in the blood, the response of the oral mucosa to CuTCPH-mediated BNCT will be governed primarily by the radiation effects of the thermal neutron beam and not from the boron neutron capture reaction [10B(n,α)7Li].</abstract><cop>United States</cop><pub>Radiation Research Society</pub><pmid>15606309</pmid><doi>10.1667/RR3272</doi><tpages>7</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0033-7587 |
| ispartof | Radiation research, 2005-01, Vol.163 (1), p.72-78 |
| issn | 0033-7587 1938-5404 |
| language | eng |
| recordid | cdi_crossref_primary_10_1667_RR3272 |
| source | JSTOR |
| subjects | Animals Blood Body Burden Boron Boron neutron capture therapy Boron Neutron Capture Therapy - adverse effects Boron Neutron Capture Therapy - methods Dose-Response Relationship, Radiation Drug Evaluation, Preclinical Epithelium Female Irradiation Lethal Dose 50 Metalloporphyrins - adverse effects Metalloporphyrins - therapeutic use Mouth Mouth Mucosa - pathology Mouth Mucosa - radiation effects Oral Ulcer - etiology Oral Ulcer - pathology Radiation dosage Radiation Injuries - etiology Radiation Injuries - pathology Radiotherapy Radiotherapy Dosage Rats Rats, Inbred F344 REGULAR ARTICLES Relative Biological Effectiveness Thermal neutrons Tissue Distribution Tongue Treatment Outcome |
| title | Porphyrin-Mediated Boron Neutron Capture Therapy: A Preclinical Evaluation of the Response of the Oral Mucosa |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T17%3A11%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Porphyrin-Mediated%20Boron%20Neutron%20Capture%20Therapy:%20A%20Preclinical%20Evaluation%20of%20the%20Response%20of%20the%20Oral%20Mucosa&rft.jtitle=Radiation%20research&rft.au=Morris,%20G.%20M.&rft.date=2005-01&rft.volume=163&rft.issue=1&rft.spage=72&rft.epage=78&rft.pages=72-78&rft.issn=0033-7587&rft.eissn=1938-5404&rft_id=info:doi/10.1667/RR3272&rft_dat=%3Cjstor_cross%3E4138631%3C/jstor_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-b327t-e8e27835afeb8a94c2d2dbe4e21bd4945c1ed98cdbe587020231f97f7ef80353%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/15606309&rft_jstor_id=4138631&rfr_iscdi=true |